Patients missing out on medicines as State haggles with pharma firms

The HSE has delivered “significant savings” in negotiations with pharmaceutical companies, including €398m in price reductions last year. Picture: Pexels

Patients with rare diseases face challenges in accessing medication because the State struggles to meet pharmaceutical companies' price demands, the Oireachtas health committee has heard.

The HSE has delivered “significant savings” in negotiations with pharmaceutical companies in efforts to make sure as many medications as possible are bought.